AVVie

AVVie

Herstellung medizinischer Geräte

Vienna, Vienna 730 Follower:innen

Advancing Transcatheter Mitral Valve Repair

Info

More than 13 million people in Europe and the US suffer from mitral valve regurgitation (blood leaking back into the heart´s left atrium) but only less then 5% of moderate to severely ill patients get treated. AVVie has developed the Mitral Butterfly (MB) system, a novel innovative solution for patients suffering from MR and subsequent heart failure. Mitral Butterfly is a hemi valve replacing the function of the native, dysfunctioning posterior leaflet. The Mitral Butterfly restores full coaptation with a nitinol-based frame and a pericardial membrane by sliding over the diseased leaflet while preserving the motion and function of the anterior leaflet. The Mitral Butterfly has been designed to prevent unphysiological inflow (regurgitation) caused by diverse pathophysiologic origins like DMR and FMR and to minimize the outflow obstruction (stenosis). The delivery can be done by both minimally invasive surgery and by transseptal delivery.

Website
www.angelvalve.com
Branche
Herstellung medizinischer Geräte
Größe
11–50 Beschäftigte
Hauptsitz
Vienna, Vienna
Art
Privatunternehmen
Gegründet
2018
Spezialgebiete
mitral regurgitation, mitral valve und medical device

Orte

Beschäftigte von AVVie

Updates

Ähnliche Seiten

Finanzierung

AVVie Insgesamt 1 Finanzierungsrunde

Letzte Runde

Zuschuss

2.441.413,00 $

Weitere Informationen auf Crunchbase